Hong Kong Energy Services Stock News

Regulatory milestone and why it matters for Alphamab Oncology Alphamab Oncology (SEHK:9966) has drawn attention after regulators in China accepted its investigational new drug application for a phase II trial of JSKN033 in first line advanced cervical cancer. The open label, multicenter study will test a high concentration subcutaneous co formulation. It combines a HER2 bispecific antibody drug conjugate with a PD L1 inhibitor, alongside platinum based chemotherapy with or without...

BYD (SEHK:1211) has just reported unaudited December 2025 production and sales figures, alongside confirmation that it surpassed Tesla as the largest seller of battery electric vehicles, putting fresh attention on how these volumes translate into margins. See our latest analysis for BYD. The latest operating data and EV leadership headlines come against a weaker share price backdrop, with a 90 day share price return decline of 12.52% and a 1 year total shareholder return of 12.23%. This...

In January 2026, Yadea Group Holdings Ltd. announced guidance for 2025, expecting net profit of at least RMB 2.90 billion, compared with RMB 1.27 billion in 2024, driven by higher electric two-wheeled vehicle sales and product mix improvements. This guidance points to a very large year-on-year profit increase, highlighting how product structure optimization may be enhancing Yadea’s earnings efficiency. With this profit guidance underpinned by stronger electric two-wheeler sales, we will now...

In early January 2026, Geely Automobile Holdings reported that it exceeded its 2025 annual sales target with over 3.02 million vehicles delivered and set a higher 2026 volume goal alongside ambitious new energy vehicle targets. Around the same time, Geely used CES 2026 to showcase its Full-Domain AI 2.0 architecture and G-ASD intelligent driving system, underscoring how AI-enabled features are becoming central to its smart vehicle offering. We’ll now explore how Geely’s launch of Full-Domain...

As global markets navigate a mix of economic signals, such as rising home sales in the U.S. and fluctuating stock indices, investors are contemplating the potential of smaller companies. Penny stocks, a term that may seem outdated but remains relevant, represent an intriguing investment area due to their potential for growth and value. In this article, we will explore three penny stocks that stand out for their financial strength and resilience, offering promising opportunities for those...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 12x, you may consider...

In early January 2026, Lenovo used Tech World @ CES in Las Vegas to unveil a sweeping Hybrid AI lineup spanning AI PCs and smartphones, new AI inferencing servers, the Lenovo and Motorola Qira personal AI super agent, and an expanded Hybrid AI Advantage enterprise stack including Agentic AI and xIQ platforms. The breadth of these launches, from edge-to-cloud AI infrastructure to cross-device personal agents and FIFA World Cup collaborations, highlights Lenovo’s attempt to position itself as...

Key Insights The projected fair value for Angelalign Technology is HK$84.38 based on 2 Stage Free Cash Flow to Equity...

As 2026 begins, Asian markets are experiencing varied momentum, with China's manufacturing sector showing signs of recovery and South Korea's exports reaching record highs. In this dynamic environment, identifying high growth tech stocks involves looking for companies that can leverage regional economic trends and technological advancements to drive innovation and capture market share.

As global markets navigate a complex economic landscape, Asian equities continue to capture investor attention with their diverse opportunities. Penny stocks, often representing smaller or newer companies, remain an intriguing segment for investors seeking growth at lower price points. Despite the term's vintage connotations, these stocks can offer significant value when backed by strong financials and clear growth potential.

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Most readers would already be aware that Nanshan Aluminium International Holdings' (HKG:2610) stock increased...

Key Insights Significant control over Cutia Therapeutics by private equity firms implies that the general public has...

Key Insights Significant control over Sipai Health Technology by retail investors implies that the general public has...

Key Insights Gushengtang Holdings' significant individual investors ownership suggests that the key decisions are...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

Key Insights Significant insider control over Hygeia Healthcare Holdings implies vested interests in company growth The...

When close to half the companies in the Construction industry in Hong Kong have price-to-sales ratios (or "P/S") below...

Key Insights Significant control over Transcenta Holding by retail investors implies that the general public has more...

Ocumension Therapeutics ( HKG:1477 ) is possibly approaching a major achievement in its business, so we would like to...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

To the annoyance of some shareholders, Yee Hop Holdings Limited ( HKG:1662 ) shares are down a considerable 30% in the...

Shanghai Conant Optical's (HKG:2276) stock is up by a considerable 35% over the past three months. Given the company's...

While it may not be enough for some shareholders, we think it is good to see the 7Road Holdings Limited ( HKG:797...